Nasdaq · CIK 0001570562
EOLS Evolus, Inc.
Insider trading from SEC Form 4. Last filing 39 d ago. Close $7.73 on Oct 9, 2026, +96% from the 52-week low and -17% from the high.
Evolus, Inc. (EOLS) has 42 SEC Form 4 filings on file from 11 insiders, the latest filed on Sep 4, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 1 open-market sell worth $950k, net -$950k.
23 open-market trades have been scored at EOLS. The newest: David Moatazedi (See Remarks) sold $950k of stock on Sep 2, 2026, filed Sep 4, 2026, scored 44 (moderate). The largest of the 23 shown: David Moatazedi (See Remarks) sold $1.4M on Mar 18, 2025, scored 40 (moderate), under a 10b5-1 plan. 2 insiders sold within 14 days of each other around Mar 20, 2026.
EOLS closed at $7.73 on Oct 9, 2026, 96% above its 52-week low and 17% below its 52-week high.
3 Form 144 notices of planned sales are on file, the latest filed Jun 16, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Evolus, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | David Moatazedi See Remarks sell | $950k 105,108 shares | -17% | - | |
| 3Weak | Rui Avelar See Remarks sell | $15k 3,119 shares | -1% | +12% from low-65% from high | |
| 11Weak | David Moatazedi See Remarks sell | $65k 13,669 shares | -2% | +12% from low-65% from high | |
| 0Weak | Rui Avelar See Remarks sell | $147k 29,996 shares | -7% | +19% from low-64% from high | |
| 12Weak | David Moatazedi See Remarks sell | $571k 116,720 shares | -16% | +19% from low-64% from high | |
| 3Weak | Rui Avelar See Remarks sell | $16k 2,261 shares | -1% | +25% from low-52% from high | |
| 11Weak | David Moatazedi See Remarks sell | $75k 10,539 shares | -3% | +25% from low-52% from high | |
| 1Weak | Tomoko Yamagishi-Dressler Chief Marketing Officer sell | $43k 5,722 shares | -6% | +33% from low-56% from high | |
| 45Moderate | Brady Stewart director buy | $204k 30,000 shares | +51% | +17% from low-62% from high | |
| 50Moderate | David Moatazedi See Remarks sell | $1.3M 127,905 shares | -26% | +8% from low-43% from high | |
| 55Moderate | Albert G White III director buy | $189k 20,000 shares | +66% | +5% from low-45% from high | |
| 16Weak | Rui Avelar See Remarks sell | $33k 3,385 shares | -1% | +7% from low-43% from high | |
| 25Weak | Sandra Beaver Chief Financial Officer sell | $65k 6,494 shares | -4% | +8% from low-42% from high | |
| 21Weak | David Moatazedi See Remarks sell | $156k 15,787 shares | -3% | +7% from low-43% from high | |
| 19Weak | David Moatazedi See Remarks sell | $78k 6,251 shares | -1% | - | |
| 25Weak | Rui Avelar See Remarks sell | $370k 27,904 shares | -7% | - | |
| 27Weak | Sandra Beaver Chief Financial Officer sell | $119k 8,996 shares | -5% | - | |
| 40Moderate | David Moatazedi See Remarks sell | $1.4M 103,376 shares | -17% | - | |
| 17Weak | Tomoko Yamagishi-Dressler Chief Marketing Officer sell | $60k 4,536 shares | -5% | - | |
| 51Moderate | Karah Herdman Parschauer director sell | $167k 12,888 shares | -29% | - | |
| 10Weak | Rui Avelar See Remarks sell | $24k 2,252 shares | -1% | - | |
| 17Weak | Sandra Beaver Chief Financial Officer sell | $17k 1,586 shares | -1% | - | |
| 20Weak | David Moatazedi See Remarks sell | $114k 10,502 shares | -2% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 16, 2025 | DAVID MOATAZEDI Officer, Director | 16,582 0.03% of outstanding | $164k | Jun 16, 2025 | $2.7M |
| Jun 13, 2025 | DAVID MOATAZEDI Officer, Director | 111,323 0.17% of outstanding | $1.1M | Jun 13, 2025 | $1.6M |
| Mar 12, 2025 | Parschauer Karah Herdman Director | 12,888 0.02% of outstanding | $167k | Mar 12, 2025 | none |
Transactions
The newest 50 of 68 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | David Moatazedi See Remarks | SOpen-market sale Common Stock | -105,108 | $9.04 | $950k | 499,592 | 39 d ago |
| Mar 20, 2026 | Rui Avelar See Remarks | SOpen-market sale Common Stock10b5-1 | -3,119 | $4.75 | $15k | 427,423 | Mar 20, 2026 |
| Mar 20, 2026 | David Moatazedi See Remarks | SOpen-market sale Common Stock10b5-1 | -13,669 | $4.75 | $65k | 604,700 | Mar 20, 2026 |
| Mar 16, 2026 | Rui Avelar See Remarks | MOption exercise Common Stock10b5-1 | +8,804 | $0.00 | $0 | 460,538 | Mar 18, 2026 |
| Mar 16, 2026 | David Moatazedi See Remarks | MOption exercise Common Stock10b5-1 | +67,489 | $0.00 | $0 | 735,089 | Mar 18, 2026 |
| Mar 17, 2026 | Rui Avelar See Remarks | SOpen-market sale Common Stock10b5-1 | -29,996 | $4.89 | $147k | 430,542 | Mar 18, 2026 |
| Mar 17, 2026 | David Moatazedi See Remarks | SOpen-market sale Common Stock10b5-1 | -116,720 | $4.89 | $571k | 618,369 | Mar 18, 2026 |
| Mar 16, 2026 | David Moatazedi See Remarks | MOption exercise Performance Restricted Stock Unitsderivative10b5-1 | -67,489 | $0.00 | $0 | 67,488 | Mar 18, 2026 |
| Mar 16, 2026 | Rui Avelar See Remarks | MOption exercise Performance Restricted Stock Unitsderivative10b5-1 | -8,804 | $0.00 | $0 | 8,802 | Mar 18, 2026 |
| Feb 17, 2026 | Albert G White III director | AGrant or award Common Stock | +45,559 | $0.00 | $0 | 95,937 | Feb 19, 2026 |
| Feb 17, 2026 | Tatjana Mitchell Chief Financial Officer | AGrant or award Common Stock | +121,489 | $0.00 | $0 | 226,092 | Feb 19, 2026 |
| Feb 17, 2026 | Rui Avelar See Remarks | AGrant or award Common Stock | +94,913 | $0.00 | $0 | 451,734 | Feb 19, 2026 |
| Feb 17, 2026 | Brady Stewart director | AGrant or award Common Stock | +45,559 | $0.00 | $0 | 134,188 | Feb 19, 2026 |
| Feb 17, 2026 | David N Gill director | AGrant or award Common Stock | +45,559 | $0.00 | $0 | 86,887 | Feb 19, 2026 |
| Feb 17, 2026 | Vikram Malik director | AGrant or award Common Stock | +45,559 | $0.00 | $0 | 321,109 | Feb 19, 2026 |
| Feb 17, 2026 | Karah Herdman Parschauer director | AGrant or award Common Stock | +45,559 | $0.00 | $0 | 77,742 | Feb 19, 2026 |
| Feb 17, 2026 | David Moatazedi See Remarks | AGrant or award Common Stock | +313,212 | $0.00 | $0 | 667,600 | Feb 19, 2026 |
| Feb 17, 2026 | David Moatazedi See Remarks | AGrant or award Performance Restricted Stock Unitsderivative | +626,424 | $0.00 | $0 | 626,424 | Feb 19, 2026 |
| Feb 17, 2026 | Tatjana Mitchell Chief Financial Officer | AGrant or award Performance Restricted Stock Unitsderivative | +121,489 | $0.00 | $0 | 121,489 | Feb 19, 2026 |
| Feb 17, 2026 | Rui Avelar See Remarks | AGrant or award Performance Restricted Stock Unitsderivative | +94,913 | $0.00 | $0 | 94,913 | Feb 19, 2026 |
| Feb 17, 2026 | David Moatazedi See Remarks | AGrant or award Stock Option (Right to Buy)derivative | +457,541 | $0.00 | $0 | 457,541 | Feb 19, 2026 |
| Feb 17, 2026 | Tatjana Mitchell Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +177,471 | $0.00 | $0 | 177,471 | Feb 19, 2026 |
| Feb 17, 2026 | Rui Avelar See Remarks | AGrant or award Stock Option (Right to Buy)derivative | +138,649 | $0.00 | $0 | 138,649 | Feb 19, 2026 |
| Dec 22, 2025 | David Moatazedi See Remarks | SOpen-market sale Common Stock10b5-1 | -10,539 | $7.15 | $75k | 354,388 | Dec 29, 2025 |
| Dec 22, 2025 | Rui Avelar See Remarks | SOpen-market sale Common Stock10b5-1 | -2,261 | $7.15 | $16k | 356,821 | Dec 29, 2025 |
| Sep 8, 2025 | Tatjana Mitchell Chief Financial Officer | AGrant or award Common Stock | +104,603 | $0.00 | $0 | 104,603 | Oct 9, 2025 |
| Sep 8, 2025 | Tatjana Mitchell Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +143,403 | $0.00 | $0 | 143,403 | Oct 9, 2025 |
| Aug 22, 2025 | Tomoko Yamagishi-Dressler Chief Marketing Officer | SOpen-market sale Common Stock10b5-1 | -5,722 | $7.51 | $43k | 89,949 | Aug 26, 2025 |
| Aug 15, 2025 | Brady Stewart director | POpen-market purchase Common Stock | +30,000 | $6.82 | $204k | 88,629 | Aug 18, 2025 |
| Jun 13, 2025 | David Moatazedi See Remarks | SOpen-market sale Common Stock | -111,323 | $10.05 | $1.1M | 381,509 | Jun 16, 2025 |
| Jun 16, 2025 | David Moatazedi See Remarks | SOpen-market sale Common Stock | -16,582 | $9.89 | $164k | 364,927 | Jun 16, 2025 |
| Jun 9, 2025 | Albert G White III director | POpen-market purchase Common Stock | +20,000 | $9.45 | $189k | 50,378 | Jun 10, 2025 |
| May 13, 2025 | Sandra Beaver Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -6,494 | $10.02 | $65k | 167,089 | May 14, 2025 |
| May 12, 2025 | Rui Avelar See Remarks | SOpen-market sale Common Stock10b5-1 | -3,385 | $9.87 | $33k | 359,082 | May 14, 2025 |
| May 12, 2025 | David Moatazedi See Remarks | SOpen-market sale Common Stock10b5-1 | -15,787 | $9.87 | $156k | 492,832 | May 14, 2025 |
| Mar 27, 2025 | David Moatazedi See Remarks | SOpen-market sale Common Stock10b5-1 | -6,251 | $12.40 | $78k | 508,619 | Mar 28, 2025 |
| Mar 18, 2025 | Rui Avelar See Remarks | SOpen-market sale Common Stock10b5-1 | -27,904 | $13.26 | $370k | 362,467 | Mar 20, 2025 |
| Mar 18, 2025 | Sandra Beaver Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -8,996 | $13.26 | $119k | 173,583 | Mar 20, 2025 |
| Mar 18, 2025 | David Moatazedi See Remarks | SOpen-market sale Common Stock10b5-1 | -103,376 | $13.26 | $1.4M | 514,870 | Mar 20, 2025 |
| Mar 18, 2025 | Tomoko Yamagishi-Dressler Chief Marketing Officer | SOpen-market sale Common Stock10b5-1 | -4,536 | $13.26 | $60k | 95,671 | Mar 20, 2025 |
| Mar 12, 2025 | Karah Herdman Parschauer director | SOpen-market sale Common Stock | -12,888 | $12.99 | $167k | 32,183 | Mar 14, 2025 |
| Mar 7, 2025 | Rui Avelar See Remarks | AGrant or award Common Stock | +23,776 | $0.00 | $0 | 390,371 | Mar 11, 2025 |
| Mar 7, 2025 | Simone Blank director | AGrant or award Common Stock | +7,364 | $0.00 | $0 | 77,111 | Mar 11, 2025 |
| Mar 7, 2025 | Sandra Beaver Chief Financial Officer | AGrant or award Common Stock | +35,663 | $0.00 | $0 | 182,579 | Mar 11, 2025 |
| Mar 7, 2025 | David Moatazedi See Remarks | AGrant or award Common Stock | +95,399 | $0.00 | $0 | 618,246 | Mar 11, 2025 |
| Mar 7, 2025 | David N Gill director | AGrant or award Common Stock | +7,364 | $0.00 | $0 | 41,328 | Mar 11, 2025 |
| Mar 7, 2025 | Brady Stewart director | AGrant or award Common Stock | +7,364 | $0.00 | $0 | 58,629 | Mar 11, 2025 |
| Mar 7, 2025 | Albert G White III director | AGrant or award Common Stock | +7,364 | $0.00 | $0 | 30,378 | Mar 11, 2025 |
| Mar 7, 2025 | Vikram Malik director | AGrant or award Common Stock | +7,364 | $0.00 | $0 | 253,878 | Mar 11, 2025 |
| Mar 7, 2025 | Karah Herdman Parschauer director | AGrant or award Common Stock | +7,364 | $0.00 | $0 | 45,071 | Mar 11, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Rui AvelarSee Remarks
- Simone Blankdirector
- Sandra BeaverChief Financial Officer
- David N Gilldirector
- David MoatazediSee Remarks
- Vikram Malikdirector
- Tatjana MitchellChief Financial Officer
- Karah Herdman Parschauerdirector, officer
- Brady Stewartdirector
- Albert G White IIIceo, president, officer, director
- Tomoko Yamagishi-DresslerChief Marketing Officer
Questions about EOLS
Answered from the filings on this page, as of the latest one.
Are insiders buying EOLS?
As of Sep 4, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 1 open-market sell worth $950k by 1 insider at Evolus, Inc. in the last 90 days, net -$950k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade EOLS on the open market?
David Moatazedi (See Remarks) sold $950k of EOLS on Sep 2, 2026 and filed the Form 4 on Sep 4, 2026. InsiderTell scored 44 (moderate).
How many insiders file Form 4 at Evolus, Inc.?
11 people have filed a Form 4 at Evolus, Inc., among them Rui Avelar (See Remarks), Simone Blank (director), Sandra Beaver (Chief Financial Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.